FUNDAMENTALS · Fundamentals · US Healthcare

Beyond Air (XAIR) Fundamentals 2026 — Revenue Analysis | SniperIQ

Beyond Air (XAIR) is a US-listed Healthcare company in Medical - Devices with a market capitalization of $4M, trading at $5.61 on the NASDAQ. This SniperIQ fundamentals page covers Beyond Air's valuation, profitability (net margin -433.0%), revenue ($8M in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap$4M
Net Margin-433.0%
Revenue (FY26)$8M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Beyond Air's market cap?

Beyond Air (XAIR) has a market capitalization of approximately $4M, trading at $5.61 on the NASDAQ. Market cap moves with the live share price.

What is Beyond Air's P/E ratio?

Beyond Air's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Beyond Air?

Beyond Air runs a net profit margin of -433.0%, a gross margin of 3.3%, and an operating margin of -378.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Beyond Air generate?

Beyond Air reported revenue of $8M for fiscal year 2026, with net income of -

3M and earnings per share (EPS) of -80.2. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Beyond Air pay a dividend?

Beyond Air does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Beyond Air financially healthy?

Beyond Air carries a debt-to-equity ratio of 3.82x and a current ratio of 3.80x, with a market beta of 0.22. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Beyond Air a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Beyond Air (XAIR) the key facts are: market cap $4M, revenue $8M, 52-week range 5.3-95.6. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Beyond Air's full fundamentals live

Get Beyond Air's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.